Wenkai Zhou
Key Laboratory Of Ocular Fundus Diseases
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cars2-Mediated Cysteine Catabolism Drives Brown Fat Development and Thermogenesis Through Persulfidating EBF2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 10, 2025
YY1 Induced FOXD2-AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2/CDKN1A Axis.
YY1 Induced FOXD2-AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2/CDKN1A Axis.
Journal: Oral diseases
Published: February 26, 2025
Comparative Proteomic Analysis of Aqueous Humor Reveals Biochemical Disparities in the Eyes of High Myopic Patients.
Journal: Journal of proteome research
Published: February 17, 2024
LINC02454-CCT complex interaction is essential for telomerase activity and cell proliferation in head and neck squamous cell carcinoma.
Journal: Cancer letters
Published: October 27, 2023
Efficacy and Safety of Implantable Collamer Lens V4c Implantation in 1,834 Myopic Eyes for 1 Year of Follow-up.
Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)
Published: October 12, 2023
Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma.
Journal: International journal of oral science
Published: July 17, 2023
Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 20, 2022
SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation.
Journal: Experimental cell research
Published: November 17, 2022
Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance.
Journal: Oral diseases
Published: July 15, 2022
CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Journal: International journal of general medicine
Published: November 05, 2021
Last Updated: 09/26/2026